Ovarian Cancer
MRC Holland Gets CE-IVDR Certification for Breast, Ovarian Cancer Syndrome Tests
The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.
BRCA2 Variants Classified in Saturation Genome Editing Studies
Research teams relied on CRISPR-Cas9-based editing and sequencing to perform high-throughput function evaluations of loss-of-function variants in exons 15 to 26 of BRCA2.
The McGill University team is advancing a test, dubbed DOvEEgene, which sequences DNA from a uterine brush sample to detect cancer-associated mutations.
The research team looked at cell-free DNA fragmentation profiles across the genome combined with measurements of two key biomarkers to detect ovarian cancer.
NHGRI to Fund Population Genomic Screening in Primary Care Network With $38.1M
Starting next year, the network will implement a population genomic screening pilot program for common, actionable genomic conditions in a primary care setting over five years.